Generazione di evidenze per la prevenzione e il trattamento del diabete attraverso l'integrazione della medicina clinica, dell'epidemiologia nutrizionale e della scienza comportamentale
Titolo originaleEvidence generation for diabetes prevention and treatment through the integration of clinical medicine, nutritional epidemiology, and behavioral science.
Diabetology international · 2027
Sintesi in italiano
Questa review narrativa esplora l'integrazione di medicina clinica, epidemiologia nutrizionale e scienza comportamentale nella prevenzione e gestione del diabete, con particolare attenzione alla qualità della dieta. L'analisi di grandi coorti statunitensi ha evidenziato che diete a base vegetale di alta qualità sono associate a un rischio ridotto di ictus e mortalità. Studi longitudinali sui biomarcatori mostrano che l'aumento dei punteggi relativi a diete vegetali salutari si collega a modifiche favorevoli nella proteina C-reattiva ad alta sensibilità, mentre l'aumento di diete vegetali meno salutari corrisponde a cambiamenti sfavorevoli nei biomarcatori infiammatori. Inoltre, profili metabolici legati a diete vegetali salutari risultano associati a un minor rischio di diabete di tipo 2. Ricerche condotte in Giappone indicano che anche piccole variazioni di peso influiscono sul rischio di diabete di tipo 2, in base all'età e all'indice di massa corporea basale. È stata osservata una correlazione tra grasso viscerale e grasso ectopico, mentre abitudini alimentari come mangiare velocemente e tardi la sera correlano con maggiore accumulo di grasso pancreatico. Negli anziani, una minore sensibilità al gusto dolce è stata associata a fragilità e peggior qualità di vita mentale. Tali risultati suggeriscono che la valutazione di qualità dietetica, stile di vita, caratteristiche metaboliche e contesto personale è cruciale; tuttavia, sono necessari studi di intervento per confermare e applicare queste evidenze a una prevenzione e cura personalizzata del diabete.
Sintesi generata con IA. Verifica metodi, risultati e limiti nella pubblicazione originale.
Abstract originale
Diet and other lifestyle factors are central to diabetes prevention and management. Effective dietary and lifestyle support requires consideration of differences in pathophysiology, food culture, and living circumstances. This narrative review summarizes our research integrating clinical medicine, nutritional epidemiology, and behavioral science, with a particular focus on diet quality. Analyses of large US cohorts showed that higher-quality plant-based diets were associated with lower risks of stroke and mortality. In longitudinal biomarker analyses, increases in healthful plant-based diet scores were associated with favorable changes in high-sensitivity C-reactive protein, whereas increases in unhealthful plant-based diet scores were associated with unfavorable changes in inflammatory biomarkers. Metabolite profiles related to healthful plant-based diets were also associated with lower type 2 diabetes risk. Building on earlier work on adiponectin and type 1 diabetes, our studies in Japan showed that even small weight changes were associated with type 2 diabetes risk, depending on age and baseline body mass index. Visceral fat correlated with ectopic fat, and fast eating and eating late at night were associated with greater pancreatic fat deposition. In older adults, lower sweet taste sensitivity was associated with frailty and poorer mental health-related quality of life. These findings suggest that diet quality and lifestyle should be assessed together with each person's metabolic characteristics and living circumstances. Intervention and implementation studies based on this largely observational evidence are the next step toward individualized diabetes prevention and care.
Parole chiave
Leggi il testo integrale originale
Testo estratto dalla pubblicazione: sono esclusi immagini, media, supplementi e parti soggette a diritti distinti.
Evidence generation for diabetes prevention and treatment through the integration of clinical medicine, nutritional epidemiology, and behavioral science
Diet and other lifestyle factors are central to diabetes prevention and management. Effective dietary and lifestyle support requires consideration of differences in pathophysiology, food culture, and living circumstances. This narrative review summarizes our research integrating clinical medicine, nutritional epidemiology, and behavioral science, with a particular focus on diet quality. Analyses of large US cohorts showed that higher-quality plant-based diets were associated with lower risks of stroke and mortality. In longitudinal biomarker analyses, increases in healthful plant-based diet scores were associated with favorable changes in high-sensitivity C-reactive protein, whereas increases in unhealthful plant-based diet scores were associated with unfavorable changes in inflammatory biomarkers. Metabolite profiles related to healthful plant-based diets were also associated with lower type 2 diabetes risk. Building on earlier work on adiponectin and type 1 diabetes, our studies in Japan showed that even small weight changes were associated with type 2 diabetes risk, depending on age and baseline body mass index. Visceral fat correlated with ectopic fat, and fast eating and eating late at night were associated with greater pancreatic fat deposition. In older adults, lower sweet taste sensitivity was associated with frailty and poorer mental health-related quality of life. These findings suggest that diet quality and lifestyle should be assessed together with each person’s metabolic characteristics and living circumstances. Intervention and implementation studies based on this largely observational evidence are the next step toward individualized diabetes prevention and care.
Introduction
Improving diet and other lifestyle factors is fundamental to the prevention and management of diabetes. The Diabetes Prevention Program, a randomized trial conducted in the United States, enrolled 3,234 adults without diabetes who had elevated fasting and post-load plasma glucose concentrations. An intensive lifestyle intervention targeting weight reduction and increased physical activity reduced the incidence of type 2 diabetes by 58% compared with placebo over a mean follow-up of 2.8 years [1]. This trial demonstrated that structured lifestyle support can prevent or delay the onset of type 2 diabetes in people at high risk.
Applying such evidence in Japan requires consideration of population characteristics. East Asian populations, including Japanese people, tend to develop type 2 diabetes at a lower body mass index (BMI). Lower insulin secretory capacity and a greater tendency to accumulate visceral fat are thought to contribute to this pattern [2, 3]. Food culture and social circumstances also influence the feasibility of lifestyle changes. Evidence generated in Japanese populations is therefore needed to develop dietary and lifestyle recommendations tailored to their metabolic characteristics and living circumstances.
We have conducted nutritional epidemiologic studies of diet and long-term health outcomes in large US cohorts, as well as clinical studies of diabetes pathophysiology and lifestyle in Japanese populations. This narrative review summarizes these studies, with an emphasis on diet quality, and considers how clinical medicine, nutritional epidemiology, and behavioral science can inform diabetes prevention and care.
Diet quality, lifestyle, and health outcomes in nutritional epidemiology
Nutritional epidemiology investigates relationships between diet, related behaviors, and health. Its scope has expanded from individual nutrients and foods to overall dietary patterns. At the Department of Nutrition, Harvard T.H. Chan School of Public Health, I examined these associations using large US cohorts, including the Nurses’ Health Study, Nurses’ Health Study II, and Health Professionals Follow-up Study. Repeated dietary assessments in these cohorts allow investigation of both habitual intake and changes in diet over time.
The quality of plant foods is an important distinction when evaluating plant-based diets. Whole grains, vegetables, legumes, and nuts differ from refined grains, sugar-sweetened beverages, and sweets in their nutritional quality and associations with health outcomes. The healthful plant-based diet index (hPDI) and unhealthful plant-based diet index (uPDI) distinguish these food groups. The hPDI gives higher scores to greater consumption of healthful plant foods and lower consumption of less healthful plant foods and animal foods. The uPDI gives higher scores to greater consumption of less healthful plant foods and lower consumption of healthful plant foods and animal foods. Thus, both indices reward lower intake of animal foods but differ in the quality of plant foods they reward. These measures enabled us to investigate how plant-based diet quality relates to clinical outcomes and biological markers (Fig. 1).
Plant-based diet quality and risks of stroke and mortality
Among 209,508 participants in the Nurses’ Health Study (NHS), Nurses’ Health Study II (NHS II), and Health Professionals Follow-up Study (HPFS), higher hPDI scores were associated with a lower risk of total stroke [4]. The multivariable-adjusted hazard ratio (HR) comparing the highest with the lowest quintile was 0.90 (95% confidence interval [CI] 0.83–0.98). The corresponding estimate for the uPDI was 1.05 (95% CI 0.96–1.15), which was not statistically significant (Fig. 1a).
We also examined changes in plant-based diet quality and subsequent mortality among 75,314 participants in the NHS and HPFS [5]. In an additional analysis of dietary changes over 16 years, each 10-point increase in the hPDI was associated with 16% lower all-cause mortality (HR 0.84, 95% CI 0.82–0.87), whereas each 10-point increase in the uPDI was associated with 20% higher mortality (HR 1.20, 95% CI 1.16–1.24; Fig. 1a). The findings show that changes in the quality of plant foods consumed are related to long-term health.
Inflammatory biomarkers and metabolite profiles
To explore biological pathways that might underlie these associations, we examined changes in diet quality and plasma biomarkers in 831 women in the NHS II with repeated blood samples approximately 13 years apart [6]. After adjustment for weight change and other covariates, a 10-point increase in the hPDI was associated with a 17.8% lower relative change in high-sensitivity C-reactive protein (hsCRP; 95% CI − 26.3% to − 8.4%). Each 10-point increase in the uPDI was associated with higher relative changes in hsCRP and interleukin-6 (IL-6), by 13.5% (95% CI 1.9–26.4%) and 12.4% (95% CI 5.2–20.1%), respectively. The association between change in the hPDI and change in IL-6 was not statistically significant (Fig. 1b).
In a complementary metabolomics study of 10,684 participants in the NHS, NHS II, and HPFS, we identified plasma metabolite profiles associated with plant-based dietary patterns and constructed hPDI-related and uPDI-related metabolite scores comprising 93 and 75 metabolites, respectively [7]. In prospective analyses, a one-standard-deviation (SD) higher hPDI-related metabolite score was associated with a 23% lower risk of type 2 diabetes (HR 0.77, 95% CI 0.71–0.84). The uPDI-related metabolite score was not significantly associated with diabetes risk (HR 1.03, 95% CI 0.95–1.11; Fig. 1c). These results help characterize the metabolic features of healthful plant-based diets and provide insight into potential mechanisms linking these diets to lower diabetes risk. Metabolite profiles may also complement self-reported dietary assessment.
Healthy dietary patterns and all-cause mortality
A study of 119,315 participants in the NHS and HPFS followed for up to 36 years compared four dietary scores: the Healthy Eating Index-2015, the Alternate Mediterranean Diet score, the hPDI, and the Alternate Healthy Eating Index [8]. Greater adherence to each pattern was associated with lower all-cause mortality. The consistent associations across multiple dietary scores support dietary recommendations that emphasize overall diet quality while allowing flexibility in food choices to accommodate individual preferences and cultural backgrounds.
Sleep duration trajectories and type 2 diabetes risk
Sleep is another potentially relevant component of diabetes prevention. Among 60,068 women in the NHS II, we examined sleep duration trajectories from early to middle adulthood in relation to subsequent type 2 diabetes [9]. Compared with a stable sleep duration of 7 h, persistently short sleep and increases or decreases in sleep duration were associated with higher diabetes risk in models adjusted for baseline characteristics and lifestyle factors. Further adjustment for BMI attenuated these associations, although the association with decreasing sleep duration remained statistically significant (HR 1.24, 95% CI 1.03–1.50). These results support considering sleep history alongside diet and physical activity.
Clinical studies of diabetes pathophysiology and lifestyle in Japan
Adiponectin and type 1 diabetes
Adiponectin is an adipocyte-derived hormone, and low circulating adiponectin concentrations are associated with visceral fat accumulation and increased metabolic risk. In an analysis of health examination data from 16,892 adults at Sumitomo Hospital, Osaka, Japan, lower serum adiponectin concentrations were associated with a greater number of borderline metabolic abnormalities, even among people without overt diabetes, hypertension, or dyslipidemia [10]. Another analysis of 21,100 Japanese adults without apparent disease found an inverse association between adiponectin concentrations and blood pressure [11]. These observations suggest that low adiponectin concentrations accompany the clustering of metabolic risk factors even in the absence of overt disease.
Alongside these studies, we conducted clinical studies of type 1 diabetes as part of the work of the Japan Diabetes Society Committee on Type 1 Diabetes Mellitus Research. We investigated factors associated with sudden death or cardiac arrest at the onset of fulminant type 1 diabetes, including the severity of hyperglycemia [12]. We also characterized type 1 diabetes associated with anti-programmed cell death-1 therapy in a nationwide survey [13]. In experimental work, we established a model mimicking viral infection using human induced pluripotent stem cell-derived insulin-producing cells, and examined the anti-apoptotic effects of a glucagon-like peptide − 1 analog [14]. Together, these studies provided a foundation for considering diabetes from both clinical and biological perspectives.
Weight change, fat accumulation, and type 2 diabetes risk
To generate evidence in Japanese populations, we analyzed data from 41,539 adults without diabetes in Kochi Prefecture, Japan, identified using the Kokuho Database, a database of health examination and health insurance claims data [15]. Compared with participants with stable body weight, defined as weight gain or loss of less than 1% over one year, those with weight loss of at least 1% had a lower subsequent risk of type 2 diabetes, whereas those with weight gain of at least 1% had a higher risk. These associations, however, differed by baseline BMI and age. Among participants with a BMI of 22 to less than 25 kg/m2, a range below the Japanese threshold for obesity, weight gain of 3% or more was associated with higher risk. In those with a BMI below 22 kg/m2, none of the individual weight-change categories was significantly associated with risk, although the trend across categories was statistically significant. No significant association was observed among participants aged 75 years or older. These findings suggest that weight gain merits attention even in people without obesity, and that weight-management goals should be individualized according to age and baseline BMI.
Body weight alone does not capture the distribution of adipose tissue. In a computed tomography study of 84 adults at Osaka University Hospital, we examined the interrelationships among visceral, subcutaneous, and ectopic fat accumulations [16]. After adjustment for age, sex, and BMI, visceral fat showed positive correlations with ectopic fat accumulation, whereas subcutaneous fat showed inverse correlations. Given the metabolic risks associated with visceral and ectopic fat accumulation, these findings highlight the importance of considering fat distribution in addition to BMI.
Eating behaviors and taste sensitivity as potential intervention targets
Among ectopic fat accumulations, pancreatic fat has gained attention because of its associations with impaired glucose tolerance and type 2 diabetes [17]. In a retrospective study of 185 adults with type 2 diabetes, we investigated pancreatic fat deposition using computed tomography [18]. Among the participants with meal-frequency data, consuming two meals per day was associated with greater pancreatic fat accumulation than consuming three meals per day. In another cross-sectional study of 99 hospitalized adults, fast eating, eating late at night, and early morning awakening were associated with greater pancreatic fat accumulation [19]. These small observational studies suggest that eating and sleep habits are associated with pancreatic fat accumulation. Intervention studies are needed to determine whether changing these habits can reduce pancreatic fat accumulation.
In Japan’s super-aged society, diabetes care for older adults needs to address frailty and health-related quality of life in addition to glycemic control. We assessed taste sensitivity in 70 older adults (mean age, 82 years) living independently in a residential community [20]. Lower sweet taste sensitivity was associated with higher frailty scores and poorer mental health-related quality of life after adjustment for age, sex, and BMI. Although the study was not restricted to people with diabetes, these findings suggest a potential role for assessing taste sensitivity and eating habits when developing tailored lifestyle support for older adults.
Conclusions and future directions
Our clinical and nutritional epidemiologic studies have identified associations of diet quality and other lifestyle factors with health outcomes relevant to diabetes. Evidence from US cohorts highlights the importance of diet quality and shows that healthful dietary patterns are associated with favorable outcomes. Studies in Japan add information on weight change, fat distribution, eating behaviors, and taste sensitivity. Together, these findings suggest that lifestyle support should be tailored to individual metabolic characteristics, food culture, and living circumstances.
Most of these findings come from observational studies, and residual confounding, measurement error, and limited generalizability should be considered when applying them to clinical practice. It is therefore essential to examine whether changes in diet and other lifestyle behaviors improve health outcomes. Our future work will build on these findings through intervention studies and the implementation of lifestyle support programs in clinical and community settings to advance individualized diabetes prevention and care.
References
1.Knowler WC Barrett-Connor E Fowler SE Hamman RF Lachin JM Walker EA Diabetes Prevention Program Research GroupReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med. 2002 346 393 403 10.1056/NEJMoa012512 11832527 PMC1370926 Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403. 10.1056/NEJMoa012512 .PMC1370926 11832527
2.Chan JCN Malik V Jia W Kadowaki T Yajnik CS Yoon KH Diabetes in Asia: epidemiology, risk factors, and pathophysiology JAMA 2009 301 2129 2140 10.1001/jama.2009.726 19470990 Chan JCN, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129–40. 10.1001/jama.2009.726 .19470990
3.Yabe D Seino Y Fukushima M Seino S β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians Curr Diab Rep 2015 15 36 10.1007/s11892-015-0602-9 25944304 PMC4420838 Yabe D, Seino Y, Fukushima M, Seino S. β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians. Curr Diab Rep. 2015;15:36. 10.1007/s11892-015-0602-9 .PMC4420838 25944304
4.Baden MY Shan Z Wang F Li Y Manson JE Rimm EB Quality of plant-based diet and risk of total, ischemic, and hemorrhagic stroke Neurology 2021 96 e1940 e1953 10.1212/WNL.0000000000011713 33692165 PMC8166423 Baden MY, Shan Z, Wang F, Li Y, Manson JE, Rimm EB, et al. Quality of plant-based diet and risk of total, ischemic, and hemorrhagic stroke. Neurology. 2021;96:e1940–53. 10.1212/WNL.0000000000011713 .PMC8166423 33692165
5.Baden MY Liu G Satija A Li Y Sun Q Fung TT Changes in plant-based diet quality and total and cause-specific mortality Circulation 2019 140 979 991 10.1161/CIRCULATIONAHA.119.041014 31401846 PMC6746589 Baden MY, Liu G, Satija A, Li Y, Sun Q, Fung TT, et al. Changes in plant-based diet quality and total and cause-specific mortality. Circulation. 2019;140:979–91. 10.1161/CIRCULATIONAHA.119.041014 .PMC6746589 31401846
6.Baden MY Satija A Hu FB Huang T Change in plant-based diet quality is associated with changes in plasma adiposity-associated biomarker concentrations in women J Nutr 2019 149 676 686 10.1093/jn/nxy301 30927000 PMC6461739 Baden MY, Satija A, Hu FB, Huang T. Change in plant-based diet quality is associated with changes in plasma adiposity-associated biomarker concentrations in women. J Nutr. 2019;149:676–86. 10.1093/jn/nxy301 .PMC6461739 30927000
7.Wang F Baden MY Guasch-Ferré M Wittenbecher C Li J Li Y Plasma metabolite profiles related to plant-based diets and the risk of type 2 diabetes Diabetologia 2022 65 1119 1132 10.1007/s00125-022-05692-8 35391539 PMC9810389 Wang F, Baden MY, Guasch-Ferré M, Wittenbecher C, Li J, Li Y, et al. Plasma metabolite profiles related to plant-based diets and the risk of type 2 diabetes. Diabetologia. 2022;65:1119–32. 10.1007/s00125-022-05692-8 .PMC9810389 35391539
8.Shan Z Wang F Li Y Baden MY Bhupathiraju SN Wang DD Healthy eating patterns and risk of total and cause-specific mortality JAMA Intern Med 2023 183 142 153 10.1001/jamainternmed.2022.6117 36622660 PMC9857813 Shan Z, Wang F, Li Y, Baden MY, Bhupathiraju SN, Wang DD, et al. Healthy eating patterns and risk of total and cause-specific mortality. JAMA Intern Med. 2023;183:142–53. 10.1001/jamainternmed.2022.6117 .PMC9857813 36622660
9.Baden MY Hu FB Vetter C Schernhammer E Redline S Huang T Sleep duration patterns in early to middle adulthood and subsequent risk of type 2 diabetes in women Diabetes Care 2020 43 1219 1226 10.2337/dc19-2371 32209646 PMC7245349 Baden MY, Hu FB, Vetter C, Schernhammer E, Redline S, Huang T. Sleep duration patterns in early to middle adulthood and subsequent risk of type 2 diabetes in women. Diabetes Care. 2020;43:1219–26. 10.2337/dc19-2371 .PMC7245349 32209646
10.Baden MY Yamada Y Obata Y Hosakawa Y Saisho K Tamba S Serum adiponectin level is not only decreased in metabolic syndrome but also in borderline metabolic abnormalities Nutr Diabetes 2011 1 e18 10.1038/nutd.2011.13 23455020 PMC3302140 Baden MY, Yamada Y, Obata Y, Hosakawa Y, Saisho K, Tamba S, et al. Serum adiponectin level is not only decreased in metabolic syndrome but also in borderline metabolic abnormalities. Nutr Diabetes. 2011;1:e18. 10.1038/nutd.2011.13 .PMC3302140 23455020
11.Baden MY Yamada Y Takahi Y Obata Y Saisho K Tamba S Association of adiponectin with blood pressure in healthy people Clin Endocrinol (Oxf) 2013 78 226 231 10.1111/j.1365-2265.2012.04370.x 22356115 Baden MY, Yamada Y, Takahi Y, Obata Y, Saisho K, Tamba S, et al. Association of adiponectin with blood pressure in healthy people. Clin Endocrinol (Oxf). 2013;78:226–31. 10.1111/j.1365-2265.2012.04370.x .22356115
12.Baden MY Imagawa A Iwahashi H Shimomura I Awata T Ikegami H Risk factors for sudden death and cardiac arrest at the onset of fulminant type 1 diabetes mellitus Diabetol Int 2016 7 281 288 10.1007/s13340-015-0247-6 30603275 PMC6224989 Baden MY, Imagawa A, Iwahashi H, Shimomura I, Awata T, Ikegami H, et al. Risk factors for sudden death and cardiac arrest at the onset of fulminant type 1 diabetes mellitus. Diabetol Int. 2016;7:281–8. 10.1007/s13340-015-0247-6 .PMC6224989 30603275
13.Baden MY Imagawa A Abiru N Awata T Ikegami H Uchigata Y Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapy Diabetol Int 2019 10 58 66 10.1007/s13340-018-0362-2 30800564 PMC6357237 Baden MY, Imagawa A, Abiru N, Awata T, Ikegami H, Uchigata Y, et al. Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapy. Diabetol Int. 2019;10:58–66. 10.1007/s13340-018-0362-2 .PMC6357237 30800564
14.Baden MY Fukui K Hosokawa Y Iwahashi H Imagawa A Shimomura I Examination of a viral infection mimetic model in human iPS cell-derived insulin-producing cells and the anti-apoptotic effect of GLP-1 analogue PLoS ONE 2015 10 e0144606 10.1371/journal.pone.0144606 26659307 PMC4676675 Baden MY, Fukui K, Hosokawa Y, Iwahashi H, Imagawa A, Shimomura I. Examination of a viral infection mimetic model in human iPS cell-derived insulin-producing cells and the anti-apoptotic effect of GLP-1 analogue. PLoS ONE. 2015;10:e0144606. 10.1371/journal.pone.0144606 .PMC4676675 26659307
15.Kagisaki T Baden MY Oyama A Noguchi M Iso H Shimomura I Effect of weight change on type 2 diabetes risk: a prospective study in a Japanese population J Clin Endocrinol Metab 2026 111 e1107 e1115 10.1210/clinem/dgaf558 41061664 PMC13017229 Kagisaki T, Baden MY, Oyama A, Noguchi M, Iso H, Shimomura I. Effect of weight change on type 2 diabetes risk: a prospective study in a Japanese population. J Clin Endocrinol Metab. 2026;111:e1107–15. 10.1210/clinem/dgaf558 .PMC13017229 41061664
16.Mitsushio K Baden MY Kagisaki T Kato S Niki A Takayama R Interrelationships among accumulations of intra- and periorgan fats, visceral fat, and subcutaneous fat Diabetes 2024 73 1122 1126 10.2337/db24-0035 38656942 PMC11189825 Mitsushio K, Baden MY, Kagisaki T, Kato S, Niki A, Takayama R, et al. Interrelationships among accumulations of intra- and periorgan fats, visceral fat, and subcutaneous fat. Diabetes. 2024;73:1122–6. 10.2337/db24-0035 .PMC11189825 38656942
17.Wagner R Eckstein SS Yamazaki H Gerst F Machann J Jaghutriz BA Metabolic implications of pancreatic fat accumulation Nat Rev Endocrinol 2022 18 43 54 10.1038/s41574-021-00573-3 34671102 Wagner R, Eckstein SS, Yamazaki H, Gerst F, Machann J, Jaghutriz BA, et al. Metabolic implications of pancreatic fat accumulation. Nat Rev Endocrinol. 2022;18:43–54. 10.1038/s41574-021-00573-3 .34671102
18.Niki A Baden MY Kato S Mitsushio K Horii T Ozawa H Consumption of two meals per day is associated with increased intrapancreatic fat deposition in patients with type 2 diabetes: a retrospective study BMJ Open Diabetes Res Care 2022 10 e002926 10.1136/bmjdrc-2022-002926 36126992 PMC9490586 Niki A, Baden MY, Kato S, Mitsushio K, Horii T, Ozawa H, et al. Consumption of two meals per day is associated with increased intrapancreatic fat deposition in patients with type 2 diabetes: a retrospective study. BMJ Open Diabetes Res Care. 2022;10:e002926. 10.1136/bmjdrc-2022-002926 .PMC9490586 36126992
19.Mitsushio K Baden MY Kato S Niki A Ozawa H Motoda S Relationships between intra-pancreatic fat deposition and lifestyle factors: a cross-sectional study Front Endocrinol (Lausanne) 2023 14 1219579 10.3389/fendo.2023.1219579 37576958 PMC10415674 Mitsushio K, Baden MY, Kato S, Niki A, Ozawa H, Motoda S, et al. Relationships between intra-pancreatic fat deposition and lifestyle factors: a cross-sectional study. Front Endocrinol (Lausanne). 2023;14:1219579. 10.3389/fendo.2023.1219579 .PMC10415674 37576958
20.Kato S Baden MY Yamabayashi E Kawamoto S Kagisaki T Mitsushio K Associations of taste sensitivity with frailty and health-related quality of life in older adults J Nutr Health Aging 2026 30 100794 10.1016/j.jnha.2026.100794 41581337 PMC12860929 Kato S, Baden MY, Yamabayashi E, Kawamoto S, Kagisaki T, Mitsushio K, et al. Associations of taste sensitivity with frailty and health-related quality of life in older adults. J Nutr Health Aging. 2026;30:100794. 10.1016/j.jnha.2026.100794 .PMC12860929 41581337
Come citare questo studio
Baden MY. (2027). Evidence generation for diabetes prevention and treatment through the integration of clinical medicine, nutritional epidemiology, and behavioral science.. Diabetology international. DOI: 10.1007/s13340-026-00948-9
Consulta la pubblicazione originale ↗